Predictors and outcome of multidrug-resistant tuberculosis

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
N SalomonD Mildvan

Abstract

We identify early predictors of multidrug-resistant tuberculosis and describe improved clinical outcomes, including survival, for patients with human immunodeficiency virus (HIV)-related multidrug-resistant tuberculosis (MDR-TB) when they are prospectively identified and receive treatment under direct observation. Analysis by means of a Cox proportional hazards model revealed that failure to defervesce while receiving a standard four-drug antituberculous regimen was independently associated with multidrug resistance (P = .004). When patients with HIV-related MDR-TB were prospectively identified and treated with at least two agents that were active in vitro, 100% bacteriologic conversion and improved survival (> or = 4 months for 88% of patients and > or = 1 year for 59% of patients) were observed. For patients with HIV-related tuberculosis, poorer survival was associated with a CD4+ lymphocyte count of < 25 mm3 (P = .03); multidrug resistance was not a predictor of poor outcome (P = .82). These data suggest that patients with prolonged fever who are receiving antituberculous therapy may be an appropriate subgroup to target for broader empirical therapy. The findings also demonstrate that improved outcomes can be achieved with H...Continue Reading

Citations

Jun 1, 1997·Social Science & Medicine·H SawertM C Raviglione
Jun 13, 1996·The New England Journal of Medicine·W R BishaiR E Chaisson
Jan 10, 2003·The New England Journal of Medicine·Carole MitnickPaul Farmer
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S LockmanJ Tappero
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S E BerningM D Iseman
Jan 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wing Wai Yew, Chi Chiu Leung
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·M Flament-SaillourJ Grosset
Jan 27, 2004·American Journal of Respiratory and Critical Care Medicine·Edward D ChanMichael D Iseman
Jul 31, 2007·Future Microbiology·Biswajit Chakrabarti, Peter D O Davies
Oct 24, 2006·Tropical Medicine & International Health : TM & IH·Jaime E Ollé-Goig
Dec 1, 1996·Infectious Disease Clinics of North America·S Segal-MaurerJ J Rahal
Jun 5, 2002·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·F A Drobniewski, Yanina M Balabanova
Nov 4, 2008·Current Opinion in Infectious Diseases·Edward D Chan, Michael D Iseman
Mar 31, 1998·Palliative Medicine·M M McKeogh
Jul 30, 2004·The Journal of Antimicrobial Chemotherapy·Giovanni Di Perri, Stefano Bonora
Jan 25, 2002·Annals of the New York Academy of Sciences·A Pozniak
Mar 1, 2002·Scandinavian Journal of Infectious Diseases·M DemissieB Lindtjorn
Aug 16, 2017·Journal of Tropical Medicine·Edson W Mollel, Jaffu O Chilongola
Jan 5, 2002·The Korean Journal of Internal Medicine·J H Lee, J H Chang
Jun 28, 2005·Annals of Saudi Medicine·Eiman MokaddasAbdul S Al-Shami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G TurettB A Fazal
American Journal of Respiratory and Critical Care Medicine
M M ParkW N Rom
Methods in Molecular Biology
F Drobniewski, A H Uttley
© 2021 Meta ULC. All rights reserved